Drug development: Time for teamwork

Nature

Volumn 509, Issue 7498 SUPPL., 2014, Pages

  May, Mike ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MK 3415A; MONOCLONAL ANTIBODY; NEW DRUG; UNCLASSIFIED DRUG;

DRUG DEVELOPMENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DRUG INDUSTRY; DRUG RESEARCH; HUMAN; INVESTMENT; PRIORITY JOURNAL; TEAMWORK;

ANTI-BACTERIAL AGENTS; DRUG DISCOVERY; DRUG INDUSTRY; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; UNITED STATES;

EID: 84899722562     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/509S4a     Document Type: Article

References (3)

1. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013 (2013).
2. World Health Organization. Global Tuberculosis Report 2013 (2013).
3. Spellberg, B. APUA Newsletter 30, 8-10 (2012).